Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Pancreatic Adenocarcinomas: Clinicopathologic and Prognostic Significance of Matrilysin Expression
- 15 February 2001
- journal article
- gastrointestinal cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (4) , 1118-1127
- https://doi.org/10.1200/jco.2001.19.4.1118
Abstract
PURPOSE: A disruption in the balance between the matrix metalloproteinases (MMPs) and their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), has been implicated in the progressi...Keywords
This publication has 49 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Matrix metalloproteinases and their inhibitors in gastric cancerGut, 1998
- Pancreatic cancerCurrent Opinion in Oncology, 1998
- Matrilysin: An epithelial matrix metalloproteinase with potentially novel functionsThe International Journal of Biochemistry & Cell Biology, 1996
- Expression and in‐situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancerInternational Journal of Cancer, 1995
- Matrix Metalloproteinase Matrilysin Is Constitutively Expressed in Adult Human Exocrine EpitheliumJournal of Investigative Dermatology, 1995
- Suppression of matrilysin inhibits colon cancer cell invasion in vitroInternational Journal of Cancer, 1995
- Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma CellsJournal of Biological Chemistry, 1995
- Expression of Matrilysin mRNA in Colorectal Adenomas and Its Induction by Truncated FibronectinBiochemical and Biophysical Research Communications, 1994
- Characterization of trypsinogens 1 and 2 in two human pancreatic adenocarcinoma cell lines; CFPAC-1 and CAPAN-1FEBS Letters, 1991